Literature DB >> 23081993

Comparison of segmentation-based attenuation correction methods for PET/MRI: evaluation of bone and liver standardized uptake value with oncologic PET/CT data.

Joong Hyun Kim1, Jae Sung Lee, In-Chan Song, Dong Soo Lee.   

Abstract

UNLABELLED: For attenuation correction (AC) in PET/MRI systems, segmentation-based methods are most often used. However, the standardized uptake value (SUV) of lesions in the bone and liver, which have higher attenuation coefficients than other organs, can be underestimated, potentially leading to misinterpretation of clinical cases. Errors in SUV estimation are also dependent on the segmentation schemes used in the segmentation-based AC. In this study, this potential bias in SUV estimation using 4 different segmentation-based AC methods was evaluated for the PET/CT data of cancer patients with bone and liver lesions.
METHODS: Forty patients who had spine or liver lesions and underwent (18)F-FDG PET/CT participated (18 women and 22 men; 20 spine lesions and 20 liver lesions; mean age (± SD), 60.5 ± 11.4 y; mean body weight, 57.7 ± 10.4 kg). The patient body region was extracted from the CT image and categorized into 5 tissue groups (air, lungs, fat, water, and bone) using Hounsfield unit thresholds, which were determined from the CT histogram. Four segmentation-based AC methods (SLA [soft-tissue/lung/air], WFLA [water/fat/lung/air], SLAB [soft-tissue/lung/air/bone], and WFLAB [water/fat/lung/air/bone]) were compared with CT-based AC. The mean attenuation coefficient for each group was calculated from 40 CT images and assigned to the attenuation maps. PET sinograms were reconstructed using segmentation- and CT-based AC maps, and mean SUV in the lesions was compared.
RESULTS: Mean attenuation coefficients for air, lungs, fat, water, and bone were 0.0058, 0.0349, 0.0895, 0.0987, and 0.1178 cm(-1), respectively. In the spine lesions, the SUVs were underestimated by 16.4% ± 8.5% (SLA AC) and 14.7% ± 7.5% (WFLA AC) but not to a statistically significant extent for SLAB and WFLAB AC relative to CT AC. In the liver lesions, the SUVs were underestimated by 11.1% ± 2.6%, 8.1% ± 3.0%, 6.8% ± 3.8%, and 4.1% ± 3.8% with SLA, SLAB, WFLA, and WFLAB AC, respectively.
CONCLUSION: Without bone segmentation, the SUVs of spine lesions were considerably underestimated; however, the bias was acceptable with bone segmentation. In liver lesions, the segmentation-based AC methods yielded a negative bias in SUV; however, inclusion of the bone and fat segments reduced the SUV bias. The results of this study will be useful for understanding organ-dependent bias in SUV between PET/CT and PET/MRI.

Entities:  

Mesh:

Year:  2012        PMID: 23081993     DOI: 10.2967/jnumed.112.104109

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  29 in total

Review 1.  Combined PET/MRI: Multi-modality Multi-parametric Imaging Is Here: Summary Report of the 4th International Workshop on PET/MR Imaging; February 23-27, 2015, Tübingen, Germany.

Authors:  D L Bailey; B J Pichler; B Gückel; H Barthel; A J Beer; J Bremerich; J Czernin; A Drzezga; C Franzius; V Goh; M Hartenbach; H Iida; A Kjaer; C la Fougère; C N Ladefoged; I Law; K Nikolaou; H H Quick; O Sabri; J Schäfer; M Schäfers; H F Wehrl; T Beyer
Journal:  Mol Imaging Biol       Date:  2015-10       Impact factor: 3.488

2.  N staging of lung cancer patients with PET/MRI using a three-segment model attenuation correction algorithm: initial experience.

Authors:  A A Kohan; J A Kolthammer; J L Vercher-Conejero; C Rubbert; S Partovi; R Jones; K A Herrmann; P Faulhaber
Journal:  Eur Radiol       Date:  2013-06-14       Impact factor: 5.315

3.  Evaluation of the PET component of simultaneous [(18)F]choline PET/MRI in prostate cancer: comparison with [(18)F]choline PET/CT.

Authors:  Axel Wetter; Christine Lipponer; Felix Nensa; Philipp Heusch; Herbert Rübben; Jens-Christian Altenbernd; Thomas Schlosser; Andreas Bockisch; Thorsten Pöppel; Thomas Lauenstein; James Nagarajah
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-10-02       Impact factor: 9.236

Review 4.  Clinical oncologic applications of PET/MRI: a new horizon.

Authors:  Sasan Partovi; Andres Kohan; Christian Rubbert; Jose Luis Vercher-Conejero; Chiara Gaeta; Roger Yuh; Lisa Zipp; Karin A Herrmann; Mark R Robbin; Zhenghong Lee; Raymond F Muzic; Peter Faulhaber; Pablo R Ros
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-03-20

5.  Quantitative simultaneous positron emission tomography and magnetic resonance imaging.

Authors:  Jinsong Ouyang; Yoann Petibon; Chuan Huang; Timothy G Reese; Aleksandra L Kolnick; Georges El Fakhri
Journal:  J Med Imaging (Bellingham)       Date:  2014-11-03

Review 6.  Functional imaging of hepatocellular carcinoma.

Authors:  Tim Ch Hoogenboom; Mark Thursz; Eric O Aboagye; Rohini Sharma
Journal:  Hepat Oncol       Date:  2016-03-29

7.  Multiatlas approach with local registration goodness weighting for MRI-based electron density mapping of head and neck anatomy.

Authors:  Reza Farjam; Neelam Tyagi; Harini Veeraraghavan; Aditya Apte; Kristen Zakian; Margie A Hunt; Joseph O Deasy
Journal:  Med Phys       Date:  2017-06-01       Impact factor: 4.071

8.  Investigation of a method for generating synthetic CT models from MRI scans of the head and neck for radiation therapy.

Authors:  Shu-Hui Hsu; Yue Cao; Ke Huang; Mary Feng; James M Balter
Journal:  Phys Med Biol       Date:  2013-11-11       Impact factor: 3.609

Review 9.  MR Imaging-Guided Attenuation Correction of PET Data in PET/MR Imaging.

Authors:  David Izquierdo-Garcia; Ciprian Catana
Journal:  PET Clin       Date:  2016-01-26

10.  Evaluation of attenuation correction in cardiac PET using PET/MR.

Authors:  Jeffrey M C Lau; R Laforest; H Sotoudeh; X Nie; S Sharma; J McConathy; E Novak; A Priatna; R J Gropler; P K Woodard
Journal:  J Nucl Cardiol       Date:  2015-10-23       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.